Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Abbisko ABSK141 KRAS-G12D Inhibitor Secures FDA IND Approval
CompanyDrug

Abbisko ABSK141 KRAS-G12D Inhibitor Secures FDA IND Approval

December 2, 2025
AbbVie Rinvoq upadacitinib CDE Priority Review Alopecia Areata China
CompanyDrug

AbbVie Rinvoq upadacitinib CDE Priority Review Alopecia Areata China

December 2, 2025
Lynk Pharma LNK01006 FDA Approval Targets TYK2 for CNS Diseases
CompanyDrug

Lynk Pharma LNK01006 FDA Approval Targets TYK2 for CNS Diseases

December 2, 2025
FDA Prasad Outlines New Vaccine Approval Process After Covid-19 Safety Analysis
Others

FDA Prasad Outlines New Vaccine Approval Process After Covid-19 Safety Analysis

December 2, 2025
China Health: Life Expectancy Hits 79 Years as Hospitals Expand and Expenditure Controlled
HospitalPolicy / Regulatory

China Health: Life Expectancy Hits 79 Years as Hospitals Expand and Expenditure Controlled

December 2, 2025
CANbridge's maralixibat Wins Hong Kong Approval for PFIC Cholestatic Pruritus
CompanyDrug

CANbridge’s maralixibat Wins Hong Kong Approval for PFIC Cholestatic Pruritus

December 2, 2025
WuXi Biologics CRDMO Qatar MOU Establishes First Middle East Center
CompanyDeals

WuXi Biologics CRDMO Qatar MOU Establishes First Middle East Center

December 2, 2025
Johnson & Johnson's Nipocalimab Secures EU Approval for Myasthenia Gravis
CompanyDrug

Johnson & Johnson’s Nipocalimab Secures EU Approval for Myasthenia Gravis

December 2, 2025
Regeneron Tessera Partner on TSRA-196 Gene-Writing Therapy for AATD with $275M Deal
CompanyDeals

Regeneron Tessera Partner on TSRA-196 Gene-Writing Therapy for AATD with $275M Deal

December 2, 2025
ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development
CompanyDeals

ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development

December 2, 2025
Microport's PulseMagic PFA-Catheter Secures NMPA Approval as First Pressure-Monitoring Device in China
CompanyMedical Device

Microport’s PulseMagic PFA-Catheter Secures NMPA Approval as First Pressure-Monitoring Device in China

December 1, 2025
Humanwell's HWS117 Long-Acting FSH Secures NMPA Clinical Trial Approval for Assisted Reproduction
CompanyDrug

Humanwell’s HWS117 Long-Acting FSH Secures NMPA Clinical Trial Approval for Assisted Reproduction

December 1, 2025
1 2 … 16 17 18 19 20 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up